VM-206 (ViroMed)

N/A

Report date: 2026/05/12 09:09:24

Base Information

Drug NameVM-206 (ViroMed)
Drug Alias NameVM-206
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsGene transference
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesViromed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReyon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A